New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2

  • Israa A. Seliem
  • , Siva S. Panda
  • , Adel S. Girgis
  • , Yassmin Moatasim
  • , Ahmed Kandeil
  • , Ahmed Mostafa
  • , Mohamed A. Ali
  • , Eman S. Nossier
  • , Fatma Rasslan
  • , Aladdin M. Srour
  • , Rajeev Sakhuja
  • , Tarek S. Ibrahim
  • , Zakaria K.M. Abdel-samii
  • , Amany M.M. Al-Mahmoudy

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Abstract

At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) and 6-fluoro-4-(2-(1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl)ethoxy)-2-(trifluoromethyl)quinoline (12c) show high potency against SARS-CoV-2. The selectivity index (SI) of compounds 10g and 12c also indicates the significant efficacy compared to the reference drugs.

Original languageEnglish (US)
Article number105117
JournalBioorganic Chemistry
Volume114
DOIs
StatePublished - Sep 2021

Keywords

  • Click chemistry
  • Molecular docking
  • Quinoline
  • SARS-CoV-2
  • Triazole

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2'. Together they form a unique fingerprint.

Cite this